A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

Mucopolysaccharidosis Type IIIB Clinical Trial

Official title:
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

Status Active, not recruiting

Clinical Trial Summary

This is a natural history study for children up to 18 years of age who have been diagnosed with Mucopolysaccharidosis Type IIIB (MPS IIIB, also known as Sanfilippo Syndrome Type B). Mucopolysaccharidosis type IIIB is a severe neurodegenerative disorder. The information gathered from this trial may help inform the design and interpretation of subsequent interventional studies. No clinical intervention or study drug is provided by Allievex in this study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03227042
Study type	Observational
Source	Allievex Corporation
Contact
Status	Active, not recruiting
Phase
Start date	November 16, 2017
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02493998` - A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
Completed	`NCT02037880` - Natural History Studies of Mucopolysaccharidosis III	N/A
Active, not recruiting	`NCT03784287` - A Treatment Extension Study of Mucopolysaccharidosis Type IIIB	Phase 2
Completed	`NCT02754076` - A Treatment Study of Mucopolysaccharidosis Type IIIB	Phase 1/Phase 2